Patents by Inventor Amy Grahn

Amy Grahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10065021
    Abstract: A catheter for delivering an agent to targeted tissue of a mammalian body including a first elongate tubular member having a proximal opening and a distal end wall. A second elongate tubular member having a portion extends through first elongate tubular member and has a distal end extending beyond the end wall. The first and second tubular members form an annular cavity within the first tubular member. A stiffening member has at least a portion disposed within the annular cavity for facilitating accurate placement of the distal end relative to the targeted tissue in the mammalian body and is removeable from the annular cavity after such placement without removal of the second elongate tubular member from the mammalian body. A method is provided.
    Type: Grant
    Filed: May 16, 2008
    Date of Patent: September 4, 2018
    Assignee: MEDGENESIS THERAPEUTIX, INC.
    Inventors: Amy Grahn, Matthias Luz
  • Publication number: 20170021019
    Abstract: Methods for treating cancer include administering a therapeutically effective amount of an immunomodulatory agent such as interferon gamma 1b in combination with a therapeutically effective amount of a PD-1 checkpoint inhibitor such as nivolumab or pembrolizumab or a therapeutically effective amount of a PD-L1 checkpoint inhibitor.
    Type: Application
    Filed: July 21, 2016
    Publication date: January 26, 2017
    Inventors: Matthew Zibelman, Elizabeth Plimack, Amy Grahn, John Gerard Devane, Jeffrey W. Sherman
  • Publication number: 20100217228
    Abstract: A catheter for delivering an agent to targeted tissue of a mammalian body including a first elongate tubular member having a proximal opening and a distal end wall. A second elongate tubular member having a portion extends through first elongate tubular member and has a distal end extending beyond the end wall. The first and second tubular members form an annular cavity within the first tubular member. A stiffening member has at least a portion disposed within the annular cavity for facilitating accurate placement of the distal end relative to the targeted tissue in the mammalian body and is removeable from the annular cavity after such placement without removal of the second elongate tubular member from the mammalian body. A method is provided.
    Type: Application
    Filed: May 16, 2008
    Publication date: August 26, 2010
    Applicant: MedGenesis Therapeutix, Inc.
    Inventors: Amy Grahn, Matthias Luz